Flip H Jansen

Summary

Affiliation: Erasmus MC
Country: The Netherlands

Publications

  1. ncbi Screening for prostate cancer in 2008 II: the importance of molecular subforms of prostate-specific antigen and tissue kallikreins
    Flip H Jansen
    Department of Urology, Erasmus MC, Rotterdam, The Netherlands
    Eur Urol 55:563-74. 2009
  2. ncbi Prostate-specific antigen (PSA) isoform p2PSA in combination with total PSA and free PSA improves diagnostic accuracy in prostate cancer detection
    Flip H Jansen
    Department of Urology, Erasmus MC, Rotterdam, The Netherlands
    Eur Urol 57:921-7. 2010
  3. ncbi Profiling of antibody production against xenograft-released proteins by protein microarrays discovers prostate cancer markers
    Flip H Jansen
    Department of Urology, Erasmus MC, 3000 CA Rotterdam, The Netherlands
    J Proteome Res 11:728-35. 2012

Detail Information

Publications3

  1. ncbi Screening for prostate cancer in 2008 II: the importance of molecular subforms of prostate-specific antigen and tissue kallikreins
    Flip H Jansen
    Department of Urology, Erasmus MC, Rotterdam, The Netherlands
    Eur Urol 55:563-74. 2009
    ..Over the past decades, prostate-specific antigen (PSA), its isoforms, and other members of the tissue kallikrein family have been of continuous interest with regard to early detection and screening for prostate cancer (PCa)...
  2. ncbi Prostate-specific antigen (PSA) isoform p2PSA in combination with total PSA and free PSA improves diagnostic accuracy in prostate cancer detection
    Flip H Jansen
    Department of Urology, Erasmus MC, Rotterdam, The Netherlands
    Eur Urol 57:921-7. 2010
    ..Novel markers for prostate cancer (PCa) detection are needed. Total prostate-specific antigen (tPSA) and percent free prostate-specific antigen (%fPSA=tPSA/fPSA) lack diagnostic specificity...
  3. ncbi Profiling of antibody production against xenograft-released proteins by protein microarrays discovers prostate cancer markers
    Flip H Jansen
    Department of Urology, Erasmus MC, 3000 CA Rotterdam, The Netherlands
    J Proteome Res 11:728-35. 2012
    ..In conclusion, this novel method allows for the identification of low abundant cancer-derived serum proteins, circumventing dynamic range and host-response issues in standard patient cohort proteomics comparisons...